Home merck
 

Keywords :   


Tag: merck

Merck KGaA CEO Says Pharmaceutical Unit Integral to Strategy

2014-01-22 16:09:42| Biotech - Topix.net

Merck KGaA is committed to its pharmaceutical business after failing to deliver new medicines as expected, Chief Executive Officer Karl-Ludwig Kley said.

Tags: unit strategy ceo integral

 

Merck Statement on FDA Advisory Committee for Vorapaxar, Merck's Investigational Antiplatelet Medicine

2014-01-16 22:12:41| Biotech - Topix.net

Merck , known as MSD outside the United States and Canada, today said it was pleased with the U.S. Food and Drug Administration 's Cardiovascular and Renal Drugs Advisory Committee's recommendation for approval of vorapaxar.

Tags: statement medicine committee advisory

 
 

Merck blood thinner gets 'yes' vote from FDA panel

2014-01-16 01:29:48| Biotech - Topix.net

A panel of federal experts has recommended approval for an experimental blood thinner from Merck despite serious side effects including internal bleeding.

Tags: vote panel blood fda

 

Merck Statement on FDA Advisory Committee for Vorapaxar, Mercks Investigational Antiplatelet Medicine

2014-01-16 00:59:00| Merck.com - Research & Development News

Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today said it was pleased with the U.S. Food and Drug Administration (FDA)s Cardiovascular and Renal Drugs Advisory Committees recommendation for approval of vorapaxar. Vorapaxar is the companys investigational antiplatelet medicine for the reduction of atherothrombotic events, when added to standard of care, in patients with a history of heart attack and no history of stroke or transient ischemic attack. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orPatrick Witmer, 267-305-4910orInvestors:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: statement medicine committee advisory

 

Merck Recalls Cholesterol Drug Liptruzet

2014-01-15 06:26:49| Biotech - Topix.net

Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock.

Tags: drug cholesterol recalls merck

 

Sites : [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] next »